Senior insider sale
President and CEO at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$2.14M
3.98K shares
What this filing means
SIBOLD WILLIAM JOHN plans to sell 3.98K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $2.14M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/26/2026ACC: 0001628280-26-003462
DirectorOfficer· President and CEO
Since Mar 2026
3.98K
Shares to sell
$2.14M
Approx. market value
1.58K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
1/23/2026
1.58KTotal acquired1.58K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2026 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 1.58K | — |
| Total | 1.58K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.40K
Market value
$1.38M
12/4/2025
Planned — Approximate Date
Nasdaq Stock MarketPlanned
Units to sell
1.58K
Market value
$757.7K
1/26/2026
Total
Units
3.98K
Value
$2.14M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/4/2025 | 2.40K | $1.38M | — | Completed |
| Planned — Approximate Date | ||||
1/26/2026 | 1.58K | $757.7K | Nasdaq Stock Market | Planned |
| Total | 3.98K | $2.14M | ||